Free Trial
OTCMKTS:CRLBF

Cresco Labs (CRLBF) Stock Price, News & Analysis

Cresco Labs logo
$0.49 -0.01 (-1.99%)
As of 02:32 PM Eastern

About Cresco Labs Stock (OTCMKTS:CRLBF)

Key Stats

Today's Range
$0.45
$0.51
50-Day Range
$0.43
$0.98
52-Week Range
$0.43
$2.05
Volume
282,838 shs
Average Volume
631,422 shs
Market Capitalization
$241.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Buy

Company Overview

Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections and fruit-forward gummies under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company was incorporated in 1990 and is headquartered in Chicago, Illinois.

Cresco Labs Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
13th Percentile Overall Score

CRLBF MarketRank™: 

Cresco Labs scored higher than 13% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Earnings Growth

    Earnings for Cresco Labs are expected to grow in the coming year, from ($0.20) to ($0.05) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cresco Labs is -2.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cresco Labs is -2.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Cresco Labs has a P/B Ratio of 0.63. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Cresco Labs' valuation and earnings.
  • Percentage of Shares Shorted

    0.15% of the float of Cresco Labs has been sold short.
  • Short Interest Ratio / Days to Cover

    Cresco Labs has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cresco Labs has recently increased by 29.34%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Cresco Labs does not currently pay a dividend.

  • Dividend Growth

    Cresco Labs does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.15% of the float of Cresco Labs has been sold short.
  • Short Interest Ratio / Days to Cover

    Cresco Labs has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cresco Labs has recently increased by 29.34%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Cresco Labs has a news sentiment score of 0.33. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.91 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Cresco Labs this week, compared to 2 articles on an average week.
  • Search Interest

    2 people have searched for CRLBF on MarketBeat in the last 30 days.
  • MarketBeat Follows

    Only 3 people have added Cresco Labs to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Cresco Labs insiders have not sold or bought any company stock.

  • Percentage Held by Institutions

    Only 0.05% of the stock of Cresco Labs is held by institutions.

  • Read more about Cresco Labs' insider trading history.
Receive CRLBF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cresco Labs and its competitors with MarketBeat's FREE daily newsletter.

CRLBF Stock News Headlines

CRLBF Cresco Labs Inc. - Seeking Alpha
I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
Exploring Cresco Labs's Earnings Expectations
See More Headlines

CRLBF Stock Analysis - Frequently Asked Questions

Cresco Labs' stock was trading at $0.9137 at the beginning of the year. Since then, CRLBF stock has decreased by 45.2% and is now trading at $0.5008.
View the best growth stocks for 2025 here
.

Cresco Labs Inc. (OTCMKTS:CRLBF) posted its quarterly earnings results on Friday, May, 30th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.03) by $0.01. The business had revenue of $165.76 million for the quarter, compared to analysts' expectations of $164.37 million. Cresco Labs had a negative net margin of 11.86% and a negative trailing twelve-month return on equity of 21.77%.

Shares of CRLBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/30/2025
Today
6/30/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:CRLBF
Fax
N/A
Employees
2,900
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$74.44 million
Pretax Margin
-3.89%

Debt

Sales & Book Value

Annual Sales
$724.34 million
Price / Cash Flow
N/A
Book Value
$0.79 per share
Price / Book
0.63

Miscellaneous

Free Float
N/A
Market Cap
$245.90 million
Optionable
Not Optionable
Beta
1.48
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (OTCMKTS:CRLBF) was last updated on 6/30/2025 by MarketBeat.com Staff
From Our Partners